Pharma

TTK Healthcare decides to sell the human pharma division. Gives it a strong reason to reward the shareholders.

TTK Healthcare (TTKH) has announced selling 100% of it’s human pharma division to Miransa Limited, an affiliate of Advent International (a major private equity investor). Key points to note – Division is being sold off to BSV Pharma Private Limited – a new entity in which 74% will be held by Miransa and balance 26% … Read more

TTK Healthcare

Biocon’s arm to acquire Viatris’ Biosimilars Assets for up to $3.33 billion

Biopharmaceutical company Biocon on Monday announced that the board of directors of Biocon Biologics Limited, a material subsidiary of Biocon Limited, has approved the proposed acquisition of biosimilars assets of Viatris Inc. The transaction is subject to necessary regulatory and other approvals. Viatris will receive consideration of up to $3.335 billion, including cash up to … Read more

Pharma industry likely to grow to $130 billion by 2030: Industry leaders

The pharmaceutical sector in the country can grow to USD 130 billion by 2030, industry captains said on Friday. He, along with other industry leaders, participated in a ‘CEOs Conclave’ as part of ‘BioAsia 2022’, the Telangana government’s flagship annual life sciences convention that concluded on Friday. “I think USD 130 billion by 2030 is … Read more

Cipla promoters selling 2.5% stake. Will be looked as negative in short term. Not for me.

Everyone needs money for varied reasons and Cipla promoters are no different. They are selling a small percentage of their holding to fund their requirements. Key points to note – The promoters own 36.1% of the Company of which they are selling about 2.5% i.e., about 6.9% of their total holding. Estimated amount that will … Read more

Cipla

Novak Djokovic holds major stake in firm developing Covid drug

Serbian tennis star Novak Djokovic, recently deported from Australia due to his coronavirus vaccine status, is co-founder and majority shareholder of a biotech firm developing a Covid-19 treatment, the Danish company’s CEO said Wednesday. “He is one of the founders of my company we founded in June 2020,” the chief executive of QuantBioRes, Ivan Loncarevic, … Read more

Ajanta Pharma decides to buyback again

The Company’s board is scheduled to meet on December 28, 2021 to take the decision. Key points to note – This is 3rd year in a row. Previous ones being Jan-Mar 2019 and Nov-Dec 2020. Jan – Mar 2019: Rs 100 crore at Rs 1,300 per share as against the then prevailing price of around … Read more